Increased graft content of vascular progenitor cells is associated with reduced toxicity following autologous hematopoietic transplantation

Experimental Hematology

Volumn 36, Issue 4, 2008, Pages 506-512

  Iqbal, Tariq ^a,b   Rajagopal, Thivisha ^c,d   Halpenny, Michael ^d   Yang, Lin ^d   Martin, Lisa ^d   Giulivi, Antonio ^b,d   McDiarmid, Sheryl ^a   Huebsch, Lothar ^a,b   Allan, David S ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; FIBRONECTIN;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLADDER DISCOMFORT; CANCER RADIOTHERAPY; CARDIOTOXICITY; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; GASTROINTESTINAL TOXICITY; GERM CELL TUMOR; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; HUMAN CELL; LENGTH OF STAY; LIVER TOXICITY; LUNG TOXICITY; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MULTIPLE SCLEROSIS; NEPHROTOXICITY; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTIGENS, CD34; ENDOTHELIAL CELLS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS;

EID: 40649100253     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.12.005     Document Type: Article

References (31)

1. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
2. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228
3. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/ macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
4. Ubrich C., Heeschen C., Aicher A., et al. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108 (2003) 2511-2516
5. Murohara T., Ikeda H., Duan J., et al. Transplanted cord blood derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105 (2000) 1527-1536
6. Rafi S., Meeus S., Dias S., et al. Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin Cell Dev Biol 13 (2002) 61-67
7. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 431-433
8. Allan D.S., Dube P., Roy J., Busque L., and Roy D.C. Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors. Biol Blood Marrow Transplant 13 (2007) 433-439
9. Asahara T., Tomono T., Masuda H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow derived endothelial progenitor cells. EMBO J 18 (1999) 3964-3972
10. Zhang Z.G., Zhang L., Jiang Q., and Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 90 (2002) 284-288
11. Shintani S., Murohara T., Ikeda H., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
12. Ghani U., Shuaib A., Salam A., et al. Endothelial progenitor cells during cerebrovascular disease. Stroke 36 (2005) 151-153
13. Gill M., Dias K., Hattori M.L., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2 (+) AC133 (-) endothelial precursor cells. Circ Res 88 (2001) 167-174
14. Bearman S.I., Appelbaum F.R., Buckner D., et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6 (1988) 1562-1568
15. Basch E., Artz D., Dulko D., et al. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol 23 (2005) 3552-3561
16. Grazzuitti M.L., Dong L., Miceli M.H., et al. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplant 38 (2006) 501-506
17. Kew A.K., Couban S., Patrick W., Thompson K., and White D. Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. Biol Blood Marrow Transplant 12 (2006) 301-305
18. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Eng J Med 348 (2003) 593-600
19. Risau W., Sariola H., Zerwes H.G., et al. Vasculogenesis and angiogenesis in embryonic-stem-cell derived embryoid bodies. Development 102 (1988) 471-478
20. Cho H.J., Kim H.S., Lee M.M., et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 108 (2003) 2918-2925
21. Lin Y., Weisdorf D.J., Solovey A., et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105 (2000) 71-77
22. Barber C.L., and Iruela-Arispe M.L. The ever-elusive endothelial progenitor cell: identities, functions and clinical implications. Pediatr Res 59 (2006) 26R-32R
23. Bailey A.S., Jiang S., Afentoulis M., et al. Transplanted adult hematopoietic stem cells differentiate into functional endothelial cells. Blood 103 (2004) 13-19
24. Fleming W.H., Alpern E.J., Uchida N., Ikuta K., and Weissman I.L. Steel factor influences the distribution and activity of murine hematopoietic stem cell in vivo. Proc Natl Acad Sci U S A 90 (1993) 3760-3764
25. Ribatti D., Vacca A., Nico B., Ria R., and Dammacco F. Cross-talk between hematopoiesis and angiogenesis signaling pathways. Curr Mol Med 2 (2002) 537-547
26. Aicher A., Heeschen C., Midner-Rihm C., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9 (2003) 1370-1376
27. Heeschen C., Aicher A., Lehmann R., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346
28. Strehlow K., Werner N., Berweiler J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107 (2003) 3059-3065
29. Walter D.H., Zeiher A.M., and Dimmeler S. Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells. Coron Artery Dis 15 (2004) 235-242
30. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
31. Takakura N., Huang X.L., Naruse T., et al. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity 9 (1998) 677-686